Myomo, Inc. (MYO)
USD 4.88
(2.95%)
USD 4.88
(2.95%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -8.14 Million USD | 24.0% |
| 2022 | -10.72 Million USD | -3.36% |
| 2021 | -10.37 Million USD | 13.84% |
| 2020 | -12.03 Million USD | -13.24% |
| 2019 | -10.63 Million USD | -3.05% |
| 2018 | -10.31 Million USD | 14.72% |
| 2017 | -12.09 Million USD | -234.46% |
| 2016 | -3.61 Million USD | 19.3% |
| 2015 | -4.48 Million USD | -27.05% |
| 2014 | -3.52 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -3.83 Million USD | -55.91% |
| 2024 Q2 | -1.12 Million USD | 70.76% |
| 2023 FY | -8.14 Million USD | 24.0% |
| 2023 Q3 | -2.02 Million USD | -100.07% |
| 2023 Q1 | -2.64 Million USD | -22.0% |
| 2023 Q4 | -2.46 Million USD | -21.25% |
| 2023 Q2 | -1.01 Million USD | 61.65% |
| 2022 Q2 | -2.9 Million USD | -3.34% |
| 2022 Q1 | -2.81 Million USD | -2.99% |
| 2022 FY | -10.72 Million USD | -3.36% |
| 2022 Q4 | -2.16 Million USD | 23.4% |
| 2022 Q3 | -2.82 Million USD | 2.72% |
| 2021 Q4 | -2.73 Million USD | -32.87% |
| 2021 Q2 | -2.62 Million USD | 11.47% |
| 2021 Q1 | -2.96 Million USD | -74.33% |
| 2021 FY | -10.37 Million USD | 13.84% |
| 2021 Q3 | -2.05 Million USD | 21.53% |
| 2020 FY | -12.03 Million USD | -13.24% |
| 2020 Q2 | -3.28 Million USD | 13.55% |
| 2020 Q3 | -2.77 Million USD | 15.53% |
| 2020 Q4 | -1.69 Million USD | 38.83% |
| 2020 Q1 | -3.8 Million USD | -37.68% |
| 2019 Q4 | -2.76 Million USD | 0.95% |
| 2019 FY | -10.63 Million USD | -3.05% |
| 2019 Q3 | -2.78 Million USD | -8.68% |
| 2019 Q2 | -2.56 Million USD | 1.26% |
| 2019 Q1 | -2.59 Million USD | 3.49% |
| 2018 Q1 | -2.34 Million USD | -23.42% |
| 2018 Q4 | -2.69 Million USD | -1.59% |
| 2018 FY | -10.31 Million USD | 14.72% |
| 2018 Q2 | -2.62 Million USD | -12.12% |
| 2018 Q3 | -2.64 Million USD | -0.77% |
| 2017 Q2 | -7.38 Million USD | -374.29% |
| 2017 Q1 | -1.55 Million USD | -28.49% |
| 2017 Q3 | -1.25 Million USD | 82.95% |
| 2017 Q4 | -1.9 Million USD | -50.94% |
| 2017 FY | -12.09 Million USD | -234.46% |
| 2016 Q4 | -1.21 Million USD | -18.96% |
| 2016 Q2 | -759.88 Thousand USD | 7.15% |
| 2016 Q3 | -1.01 Million USD | -34.0% |
| 2016 Q1 | -818.43 Thousand USD | 25.13% |
| 2016 FY | -3.61 Million USD | 19.3% |
| 2015 FY | -4.48 Million USD | -27.05% |
| 2015 Q1 | -1.14 Million USD | 0.0% |
| 2015 Q4 | -1.09 Million USD | 0.0% |
| 2015 Q3 | -1.09 Million USD | 4.77% |
| 2015 Q2 | -1.14 Million USD | 0.0% |
| 2014 FY | -3.52 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Abbott Laboratories | 5.72 Billion USD | 100.142% |
| Allurion Technologies Inc. | -82.3 Million USD | 90.101% |
| Artivion, Inc. | -30.69 Million USD | 73.452% |
| Avanos Medical, Inc. | -61.8 Million USD | 86.816% |
| Butterfly Network, Inc. | -133.69 Million USD | 93.906% |
| Butterfly Network, Inc. | -133.69 Million USD | 93.906% |
| Bio-Rad Laboratories, Inc. | -637.32 Million USD | 98.722% |
| Boston Scientific Corporation | 1.59 Billion USD | 100.511% |
| CONMED Corporation | 64.45 Million USD | 112.64% |
| Edwards Lifesciences Corporation | 1.4 Billion USD | 100.581% |
| Paragon 28, Inc. | -47.84 Million USD | 82.969% |
| Glaukos Corporation | -134.66 Million USD | 93.95% |
| Globus Medical, Inc. | 122.87 Million USD | 106.631% |
| Inspire Medical Systems, Inc. | -21.15 Million USD | 61.483% |
| Integer Holdings Corporation | 90.65 Million USD | 108.988% |
| Medtronic plc | 3.67 Billion USD | 100.222% |
| Nevro Corp. | -92.21 Million USD | 91.164% |
| Owlet, Inc. | -32.9 Million USD | 75.236% |
| Penumbra, Inc. | 90.95 Million USD | 108.958% |
| Vicarious Surgical Inc. | -71.07 Million USD | 88.536% |
| Smith & Nephew plc | 263 Million USD | 103.098% |
| STERIS plc | 378.23 Million USD | 102.154% |
| Stryker Corporation | 3.16 Billion USD | 100.257% |
| Vapotherm, Inc. | -58.19 Million USD | 85.999% |
| Zimmer Biomet Holdings, Inc. | 1.02 Billion USD | 100.796% |